Gammagard Side Effects
Generic Name: immune globulin intravenous and subcutaneous
Note: This document contains side effect information about immune globulin intravenous and subcutaneous. Some of the dosage forms listed on this page may not apply to the brand name Gammagard.
Some side effects of Gammagard may not be reported. Always consult your doctor or healthcare specialist for medical advice. You may also report side effects to the FDA.
For the Consumer
Applies to immune globulin intravenous and subcutaneous: injection
Check with your doctor if any of these most COMMON side effects persist or become bothersome:
Seek medical attention right away if any of these SEVERE side effects occur while taking immune globulin intravenous and subcutaneous (the active ingredient contained in Gammagard)
Chills; cough; diarrhea; dizziness; flushing; headache; joint or back pain; mild sore throat; mild stomach pain; muscle pain, weakness, or cramps; mild pain, swelling, bruising, warmth, or redness at the injection site; nausea; runny or stuffy nose; tiredness or weakness; vomiting.
Severe allergic reactions (rash; itching; hives; difficulty breathing or swallowing; tightness in the chest; swelling of the mouth, hands, face, lips, eyes, throat, or tongue); blue lips, fingers, or toes; blurred vision or other vision problems; calf or leg pain, swelling, redness, or tenderness; chest, jaw, or arm pain; confusion; coughing up blood; dark or red urine; ear pain; eye pain or sensitivity to light; fainting; fast or irregular heartbeat; fever; mental or mood changes; mouth sores; numbness of the face, arm, or leg; one-sided weakness; red, swollen, blistered, or peeling skin; seizures; severe headache, dizziness, or stomach pain; severe or persistent pain, swelling, or redness at the injection site; shortness of breath or trouble breathing; sluggishness; speech problems; sudden nausea or vomiting; sudden unusual sweating; swelling of the hands, ankles, or feet; symptoms of kidney problems (eg, decreased urination, lower back or flank pain, shortness of breath, swelling or bloating, sudden weight gain); symptoms of liver problems (eg, pale stools, nausea, stomach pain, loss of appetite); unusual bruising or bleeding; unusual tiredness or weakness; wheezing; yellowing of the skin or eyes.
For Healthcare Professionals
Applies to immune globulin intravenous and subcutaneous: injectable solution
Dermatologic side effects have included injection site reactions, rash, erythema, pain, swelling, ecchymosis, purpura, petechia, pruritus, urticaria, Stevens-Johnson syndrome, epidermolysis, erythema multiforme, bullous dermatitis, and hives.
Cardiovascular side effects have included hypertension, cardiac arrest, thromboembolism, vascular collapse, and hypotension.
Hypersensitivity side effects have included anaphylaxis.
General side effects have included accidental injury, ear pain, and cough.
Immunologic side effects have included have included influenza, flu syndrome, and aseptic meningitis. All U.S. immune globulin products undergo viral inactivation and/or removal; however, no method has been totally effective in removing all risk and the potential exists for the presence of unknown infectious agents.
Hematologic side effects have included hemorrhage (all systems), epistaxis, thrombocytopenia, anemia, hemolytic anemia, pancytopenia, leucopenia, hemolysis, and positive direct antiglobulin (Coombs test).
Musculoskeletal side effects have included arthralgia, back pain, neck pain, and rigors.
Nervous system side effects have included headache, dizziness, fatigue, coma, loss of consciousness, seizures, and tremor.
Metabolic side effects have included pyrexia, chills, and asthenia.
Gastrointestinal side effects have included nausea, vomiting, abdominal pain, and dyspepsia.
Respiratory side effects have included rhinitis, pharyngitis, asthma, apnea, acute respiratory distress syndrome (ARDS), transfusion related acute lung injury (TRALI), cyanosis, hypoxemia, pulmonary edema, dyspnea, and bronchospasm.
Hepatic side effects have included hepatic dysfunction and transient elevations (less than 3 times the upper limit) of ALT and AST.
More about Gammagard (immune globulin intravenous and subcutaneous)
- Other brands: Gamunex-C
Compare with other treatments for:
Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This material does not endorse drugs, diagnose patients, or recommend therapy. This information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate safety, effectiveness, or appropriateness for any given patient. Drugs.com does not assume any responsibility for any aspect of healthcare administered with the aid of materials provided. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the substances you are taking, check with your doctor, nurse, or pharmacist.